S. 2720 · 117th Congress · Senate

Veterans’ Prostate Cancer Treatment and Research Act

Active· Committee on Veterans' Affairs. Ordered to be reported without amendment favorably.
Introduced
Sep 13, 21
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Veterans' Prostate Cancer Treatment and Research Act

This bill requires the Department of Veterans Affairs (VA) to establish in its National Surgery Office an interdisciplinary clinical pathway for all stages of prostate cancer. Clinical pathways are health care management tools designed around research and evidence-based practices that provide direction for the care and treatment of a specific condition. The clinical pathway must include specified elements, such as a diagnosis pathway and a treatment pathway.

The VA must consult with and incorporate feedback from (1) veterans who have received prostate cancer care at its medical facilities, and (2) experts in multidisciplinary cancer care and clinical research.

Additionally, the VA must publish the clinical pathway on a public VA website and annually update the pathway as needed based on medical literature and evidence-based guidelines.

The bill also requires the VA to submit a plan to establish a prostate cancer program using the comprehensive prostate cancer clinical pathway.

Action Timeline

4
  1. DEC 15, 2021Committee

    Committee on Veterans' Affairs

    Ordered to be reported without amendment favorably.

  2. OCT 20, 2021Committee

    Committee on Veterans' Affairs. Hearings held.

  3. SEP 13, 2021IntroReferral

    Introduced in Senate

  4. SEP 13, 2021IntroReferral

    Read twice and referred to the Committee on Veterans' Affairs.

Committees

3

Veterans' Affairs Committee

ssva00

Referred: Dec 15, 2021

Active

Veterans' Affairs Committee

ssva00

Referred: Oct 20, 2021

Active

Veterans' Affairs Committee

ssva00

Referred: Sep 13, 2021

Active